List of medications

Ministerial order – List of medications, December 20, 2024
List of medications, December 12, 2024
- Ministerial order – List of medications, December 12, 2024
- Notice of correction made to the List of medications, December 12, 2024

Regulation respecting the List of medications covered by the basic prescription drug insurance plan (CQLR, chapter A-29.01, r. 3)

The List of medications constitutes a regulatory list of the medications covered by Québec’s basic prescription drug insurance plan. See list update schedule.

For previous versions of the list, see the register below. The "Related legal document" links point to the minister’s orders and RAMQ notices pertaining to the list.

Please note that under the seventh paragraph of section 60 and section 60.1 of the Act respecting prescription drug insurance (CQLR, chapter A-29.01), publication on this website of a regulation respecting the List of medications and of the Related legal documents imparts authentic value to them.

Notices of replacement

Notice of alternative medication authorization, December 2, 2024 – Praziquantel replaces Biltricide
Notice of alternative medication authorization, November 26, 2024 – Pentoxifylline replaces Pentoxifylline SR
Notice of alternative medication authorization, November 18, 2024 – Diazepam replaces:
- Diastat 1 mL (5 mg)
- Diastat 2 mL (10 mg)
- Diastat 3 mL (15 mg)
Notice of alternative medication authorization, November 12, 2024 – Megestrol acetate replaces Megestrol
Notice of alternative medication authorization, October 16, 2024 – Clindamycin palmitate hydrochloride replaces Dalacin C
Notice of alternative medication authorization, September 12, 2024 – Isotretinoin replaces:
- Accutane 10
- Clarus

Notice of alternative medication authorization, December 2, 2024 – Praziquantel replaces Biltricide
Notice of alternative medication authorization, November 26, 2024 – Pentoxifylline replaces Pentoxifylline SR
Notice of alternative medication authorization, November 18, 2024 – Diazepam replaces:
- Diastat 1 mL (5 mg)
- Diastat 2 mL (10 mg)
- Diastat 3 mL (15 mg)
Notice of alternative medication authorization, November 12, 2024 – Megestrol acetate replaces Megestrol
Notice of alternative medication authorization, October 16, 2024 – Clindamycin palmitate hydrochloride replaces Dalacin C
Notice of alternative medication authorization, September 12, 2024 – Isotretinoin replaces:
- Accutane 10
- Clarus
Notice of alternative medication authorization, August 20, 2024 – Megestrol acetate replaces Megestrol
Notice of alternative medication authorization, August 21, 2024 – Gemfibrozil replaces Teva-Gemfibrozil
Notice of alternative medication authorization, August 12, 2024 – Phenobarbital replaces Phenobarb elixir
Notice of alternative medication authorization, July 29, 2024 – Methazolamide (99114359) (99114364) replaces Methazolamide (02245882)
Notice of alternative medication authorization, July 18, 2024 – Polystyrene sodium sulfonate replaces:
- Odan-Sodium polystyrene sulfonate
- Solystat
Notice of alternative medication authorization, July 15, 2024 – Methylprednisolone replaces Medrol
Notice of alternative medication authorization, July 15, 2024 – Methazolamide (99114359) replaces Methazolamide (02245882)
Notice of alternative medication authorization, July 9, 2024 – Sulfasalazine replaces Pms-Sulfasalazine-E.C.
Notice of alternative medication authorization, June 26, 2024 – Abatacept replaces Orencia
Notice of alternative medication authorization, June 20, 2024 – Collagenase replaces Santyl
Notice of alternative medication authorization, June 19, 2024 – Diclofenac sodium/misoprostol replaces:
- Arthrotec
- Pms-Diclofenac-Misoprostol
Notice of alternative medication authorization, June 14, 2024 – Niacine replaces:
- Jamp-Niacine
- Niacine
Notice of alternative medication authorization, June 19, 2024 – Carbamazepine replaces:
- Taro-Carbamazepine
- Tegretol
- Pms-Carbamazepine CR
- Sandoz Carbamazepine CR
- Tegretol CR
Notice of alternative medication authorization, June 13, 2024 – Nitrofurantoin monohydrate (macrocrystals) replaces Teva-Nitrofuratoïn
Notice of alternative medication authorization, May 14, 2024 – Tamoxifen citrate replaces:
- Apo-Tamox
- Teva-Tamoxifen
Notice of alternative medication authorization, May 19, 2024 – Folique acid replaces:
- Sandoz Folic Acid
- Jamp-Acide Folique
Notice of alternative medication authorization, May 14, 2024 – Nystatine replaces:
- Jamp-Nystatin
- Pms-Nystatin
- Ratio-Nystatin
Notice of alternative medication authorization, April 23, 2024 – Nystatine replaces Nyaderm
Notice of alternative medication authorization, April 22, 2024 – Tretinoin replaces Vitamin A Acid Gel
Notice of alternative medication authorization, March 22, 2024 – Verapamil hydrochloride replaces:
- Apo-Verap
- Mylan-Verapamil
Notice of alternative medication authorization, March 25, 2024 – Dexlansoprazole replaces Dexilant
Notice of alternative medication authorization, March 12, 2024 – Methadone hydrochloride replaces Metadol
Notice of alternative medication authorization, March 12, 2024 – Cholestyramine resin replaces:
- Cholestyramine-Odan
- Jamp-Cholestyramine
Notice of alternative medication authorization, March 11, 2024 – Pizotifen malate replaces Sandomigran DS
Notice of alternative medication authorization, February 29, 2024 – Galantamine hydrobromide replaces:
- Auro-Galantamine ER
- Galantamine ER
- Mylan-Galantamine ER
Notice of alternative medication authorization, August 18, 2022 – Electrolyte replacement/dextrose replaces Jamp Rehydralyte
Notice of alternative medication authorization, February 21, 2024 – Fluorouracil replaces Efudex
Notice of alternative medication authorization, February 1 and 13, 2024 – Methadone hydrochloride in a concentration of 1 mg (effective February 1, 2024) and in a concentration of 5 mg (effective February 13, 2024)
Notice of alternative medication authorization, February 5, 2024 – Glucagon replaces:
- GlucaGen
- GlucaGen HypoKit
- Glucagon
Notice of alternative medication authorization, February 2, 2024 – Potassium chloride remplaces Pms-potassium chloride
Notice of alternative medication authorization, December 22, 2023 – Dulaglutide replaces:
- Victoza liraglutide (rupture Trulicity)
- Ozempic liraglutide (rupture Trulicity)
Notice of alternative medication authorization, October 3, 2023 – Cholestyramine resin replaces:
- Cholestyramine-Odan
- Jamp-Cholestyramine (02478595)
- Jamp-Cholestyramine (02494531)
Notice of alternative medication authorization, November 29, 2023 – Fluvastatine sodium replaces Teva Fluvastatin
Notice of alternative medication authorization, December 11, 2023 – Risperidone tartrate replaces:
- Jamp-Risperidone
- Pms-Risperidone
Notice of alternative medication authorization, December 22, 2023 – Victoza liraglutide (rupture) and Trulicity dulaglutide (rupture) and Semaglutide replace Semaglutide (Ozempic)
Notice of alternative medication authorization, December 21, 2023 – Quinapril hydrochloride replaces:
- Accupril
- Apo-Quinapril
- pms-Quinapril
Notice of alternative medication authorization, December 28, 2023 – Tamsulosin hydrochloride replaces:
- Apo-Tamsulosin CR
- Flomax CR
- Novo-Tamsulosin
- Ratio-Tamsulosin
- Sandoz Tamsulosin
- Sandoz Tamsulosin CR
- Tamsulosin CR
- Teva-Tamsulosin CR

Notice of alternative medication authorization, October 4, 2023 – Cholestyramin resin replaces:
- Cholestyramine-Odan
- Jamp-Cholestyramine (02478595)
- Jamp-Cholestyramine (02494531)
Notice of alternative medication authorization, December 4, 2023 – Glyceryl trinitrate replaces:
- Mylan-Nitro SL Spray
- Nitrolingual Pompe
- Rho-Nitro
Notice of alternative medication authorization, November 22, 2023 – Sodium chloride replaces Nebusal 7 %
Notice of alternative medication authorization, November 13, 2023 – Victoza liraglutide (rupture) and Trulicity dulaglutide (rupture) replace Semaglutide (Ozempic)
Notice of alternative medication authorization, November 6, 2023 – Carbamazepine replaces:
- Taro-Carbamazepine
- Tegretol
Notice of alternative medication authorization, November 1, 2023 – Vigabatrin replaces Sabril
Notice of alternative medication authorization, October 18, 2023 – Epinephrine hydrochloride replaces Epinephrine
Notice of alternative medication authorization, September 13, 2023 – Valganciclovir hydrochloride replaces Valcyte
Notice of alternative medication authorization, October 17, 2023 – Nutritional formula – Monogen Nutricia replaces Portagen
Notice of alternative medication authorization, October 13, 2023 – Niraparib tosylate replaces Zejula
Notice of alternative medication authorization, October 16, 2023 – Prazosin hydrochloride replaces Teva-Prazosin
Notice of alternative medication authorization, September 25, 2023 – Chlordiazepoxide hydrochloride replaces Chlordiazepoxide
Notice of alternative medication authorization, September 25, 2023 – Diazepam replaces:
- Diastat 1 mL (5 mg)
- Diastat 2 mL (10 mg)
- Diastat 3 mL (15 mg)
Notice of alternative medication authorization, September 7, 2023 – Valganciclovir hydrochloride replaces Valcyte
Notice of alternative medication authorization, August 21, 2023 – Atropine sulfate replaces:
- Atropine
- Isopto Atropine
Notice of alternative medication authorization, August 31, 2023 – Folic acid replaces:
- Jamp-Folic Acid
- M-Folique 1 mg
Notice of alternative medication authorization, June 19, 2023 – Indomethacin replaces Sandoz Indomethacin
Notice of alternative medication authorization, June 6, 2023 – Medroxyprogesterone acetate replaces:
- Apo-Medroxy
- Novo-Medrone
Notice of alternative medication authorization, July 17, 2023 – Megestrol acetate replaces Megestrol acetate
Notice of alternative medication authorization, July 6, 2023 – Metronidazole replaces diphenhydramine hydrochloride
Notice of alternative medication authorization, June 6, 2023
- Medroxyprogesterone acetate (99114209) remplaces:
  - Apo-Medroxy
  - Novo-Medrone
- Medrozyprogesterone acetate (99114210) replaces Apo-Medroxy
Notice of alternative medication authorization, June 14, 2023 – Vigabatrin replaces Sabril
Notice of alternative medication authorization, June 16, 2023 – Metronidazole replaces Nidagel
Notice of alternative medication authorization, June 6, 2023 – Medroxyprogesterone acetate replaces:
- Apo-Medroxy
- Novo-Medrone
Notice of alternative medication authorization, June 2, 2023 – Mexiletine hydrochloride replaces Teva-Mexiletine
Notice of alternative medication authorization, June 1, 2023 – Paraffin/Mineral oil replaces Lacrilube
Notice of alternative medication authorization, June 1, 2023 – Progesterone replaces ACT Progesteron Injection
Notice of alternative medication authorization, May 31, 2023:
- Prazosin hydrochloride, capsules, 0.5 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
- Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg
Notice of alternative medication authorization, May 10, 2023:
- Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
- Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg
Notice of alternative medication authorization, May 5, 2023 – Hydroxyzine hydrochloride replaces:
- Hydroxyzine
- Teva-Hydroxyzin
Notice of alternative medication authorization, April 28, 2023 – Cyclopentolate hydrochloride replaces:
- Cyclogil
- Odan-Cyclopentolate
Notice of alternative medication authorization, April 28, 2023 – Atropine sulfate replaces:
- Atropine
- Isopto Atropine
Notice of alternative medication authorization, April 20, 2023 – Clindamycin phosphate replaces Taro-Clindamycin
Notice of alternative medication authorization, April 13, 2023 – Prednisolone acetate replaces:
- Ratio-Prednisolone
- Sandoz Prednisolone
Notice of alternative medication authorization, April 13, 2023 – Trifluoperazine hydrochloride replaces Trifluoperazine
Notice of alternative medication authorization, March 30 2023 – Quinapril hydrochloride 5 mg, 10 mg, 20 mg et 40 mg replace:
- Accupril
- Apo-Quinapril
- pms-Quinapril
Notice of alternative medication authorization, March 14, 2023 – Thiamine hydrochloride replaces Thiamiject
Notice of alternative medication authorization, March 9, 2023 – Minoxidil replaces Loniten
Notice of alternative medication authorization, December 28, 2022 – Propranolol hydrochloride replaces Teva-Propranolol
Notice of alternative medication authorization, February 28, 2023 – Hydroxyzine hydrochloride rempaces:
- Hydroxyzine
- Novo-Hydroxyzin
Notice of alternative medication authorization, February 27, 2023 – Ergocalciferol replaces Jamp-D2-Dol
Notice of alternative medication authorization, February 16, 2023 – Imipenem/Cilastatin sodium replaces Taro-Imipenem-Cilastatin
Notice of alternative medication authorization, February 16, 2023:
- Prazosin hydrochloride 1 mg remplace Teva-Prazosin 1 mg
- Prazosin hydrochloride 2 mg remplace Teva-Prazosin 2 mg
- Prazosin hydrochloride 5 mg remplace Teva-Prazosin 5 mg
Notice of alternative medication authorization, January 30, 2023 – Folic acid replaces:
- Euro-Folic
- Jamp-Folic Acid
Notice of alternative medication authorization, January 5, 2023 – Furosemide replaces Lasix Special
Notice of alternative medication authorization, January 4, 2023 – Gentamicin sulfate replaces Gentamicin Injection
Notice of alternative medication authorization, December 6, 2022 – Nifedipine replaces Nifedipine
Notice of alternative medication authorization, November 7, 2022 – Amoxicillin replaces:
- Amoxicillin
- Apo-Amoxi
- Auro-Amoxicillin
- Novamoxin
- Novamoxin-250
- pms-Amoxicillin
- Pro-Amox-250

Notice of alternative medication authorization, December 28, 2022 – Rifampin 150 mg et 300 mg replace:
- Rofact 150
- Rofact 300
Notice of alternative medication authorization, December 16, 2022 – Codeine phosphate, 25 mg/5 ml, Syr. replaces Codeine
Notice of alternative medication authorization, December 16, 2022 – Codeine phosphate, 30 mg, Caps. replaces:
- Codeine
- Teva-Codeine
Notice of alternative medication authorization, December 13, 2022 – Propranolol hydrochloride replaces Teva-Propranolol
Notice of alternative medication authorization, December 6, 2022 – Heparine sodium replaces Heparin sodium injection, USP
Notice of alternative medication authorization, December 6, 2022 – Heparine sodium replaces Heparin sodium injection, USP
Notice of alternative medication authorization, December 6, 2022 – Nifedipine replaces Nifedipine
Notice of alternative medication authorization, December 2, 2022 – Acetylcysteine solution replaces Acetylcysteine
Notice of alternative medication authorization, December 1, 2022 – Minoxidil replaces Loniten
Notice of alternative medication authorization, November 24, 2022 – Amoxicillin/Potassium clavulanate replaces Clavulin-400
Notice of alternative medication authorization, October 14, 2022 – Haloperidol replaces Teva-Haloperidol
Notice of alternative medication authorization, November 15, 2022 – Spironolactone replaces:
- Jamp Spironolactone
- Mint-Spironolactone
- Teva-Spironolactone
Notice of alternative medication authorization, November 7, 2022 – Quinine sulfate replaces:
- Jamp-Quinine
- Novo-Quinine
- Pro-Quinine-200
- Quinine-Odan (Caps.)
Notice of alternative medication authorization, November 3, 2022 – Atropine sulfate replaces:
- Atropine
- Isopto Atropine
Notice of alternative medication authorization, November 16, 2022 – Diphenhydramine (chlorhydrate de) replaces Diphenhydramine (chlorhydrate de)
Notice of alternative medication authorization, October 31, 2022 – Spironolactone replaces:
- Jamp Spironolactone
- Mint-Spironolactone
- Teva-Spironolactone
Notice of alternative medication authorization, October 28, 2022 – Ibuprofene replaces Europrofen
Notice of alternative medication authorization, October 24, 2022 – Estradiol-17B replaces Estrogel
Notice of alternative medication authorization, October 24, 2022 – Prochlorperazine replaces Sandoz Prochloperazine
Notice of alternative medication authorization, September 2, 2022 – Sulfasalazine replaces Pms-Sulfasalazine-E.C
Notice of alternative medication authorization, October 14, 2022 – Haloperidol replaces Teva-Haloperidol
Notice of alternative medication authorization, October 17, 2022 – Acetaminophene replace:
- Jamp-Acetaminophene
- Pediatrix
Notice of alternative medication authorization, October 13, 2022 – Betamethasone valerate replaces Betaderm Taro
Notice of alternative medication authorization, October 7, 2022 – Oxycodone hydrochloride 10 mg and 20 mg replace Supeudol Sandoz
Notice of alternative medication authorization, October 5, 2022 – Amoxicillin/Potassium clavulanate replaces GSK Clavulin-400
Notice of alternative medication authorization, September 16, 2022 – Penicillin G Sodium replaces Penicillin G
Notice of alternative medication authorization, August 22, 2022 – Heparin sodium replaces Heparin sodium injection, USP
Notice of alternative medication authorization, August 18, 2022 – Electrolyte replacement/dextrose replace:
- Gastrolyte
- Jamp Rehydralyte
Notice of alternative medication authorization, August 16, 2022 – Trifluoperazine hydrochloride replaces Trifluoperazine
Notice of alternative medication authorization, August 16, 2022 – Trifluoperazine hydrochloride (5 mg – Caps.), Trifluoperazine hydrochloride (10 mg – Caps.), and Trifluoperazine hydrochloride (20 mg – Caps.) replace:
- Trifluoperazine hydrochloride (5 mg – Tab.)
- Trifluoperazine hydrochloride (10 mg – Tab.)
- Trifluoperazine hydrochloride (20 mg – Tab.)
Notice of alternative medication authorization, August 8, 2022 – Hydroxyzine hydrochloride replaces:
- Hydroxyrine
- Novo-Hydroxyzin
Notice of alternative medication authorization, August 8, 2022 – Acetaminophen (160 mg/5 ml – Liq.), and Acetaminophen (160 mg/5 ml – Liq.) replace:
- Acetaminophen
- Jamp-Acetaminophen
- PDP-Acetaminophen solution
Notice of alternative medication authorization, July 29, 2022 – Diphenhydramine hydrochloride replaces Diphenhydramine hydrochloride
Notice of alternative medication authorization, July 18, 2022 – Nutritional formula – infants and children (Althéra UK) and Nutritional formula – infants and children (Alfamino UK) replace:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
Notice of alternative medication authorization, July 11, 2022 – Tocilizumab (162 mg/0.9 ml (4 ml)), Tocilizumab (162 mg/0.9 ml (10 ml)) and Tocilizumab (162 mg/0.9 ml (20 ml)) replace:
- Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (syr)
- Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (pen)
Notice of alternative medication authorization, June 27, 2022 – Nutritional formula – infants and children (Similac Alimentum US 946 ml) replaces:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
Notice of alternative medication authorization, June 17, 2022 – Diazapam replaces:
- Diastat 1 ml (5 mg)
- Diastat 2 ml (10 mg)
Notice of alternative medication authorization, June 17, 2022 – Imipenem/Cilastatin sodium replaces Primaxin
Notice of alternative medication authorization, June 17, 2022 – Hydrocortisone replaces Cortef
Notice of alternative medication authorization, June 15, 2022 – Minoxidil replaces Loniten
Notice of alternative medication authorization, June 14, 2022 – Nutritional formula – infants and children (Nestlé Gerber Good Start Extensive HS – imported) remplaces:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
Notice of alternative medication authorization, June 10, 2022 – Insulin lispro replaces Admelog SanofiAven
Notice of alternative medication authorization, May 31, 2022 – Nutritional formula – infants and children (Nutramigen A+ concentrated – imported) rempaces:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
Notice of alternative medication authorization, May 26, 2022 – Terbutatine sulfate replaces Bricanyl Turbuhaler
Notice of alternative medication authorization, May 18, 2022 – Octreotide acetate (99113996) replaces Sandostatin
Notice of alternative medication authorization, May 17, 2022 – Minoxidil (99113991) replaces Loniten
Notice of alternative medication authorization, May 17, 2022 – Minoxidil (99113992) replaces Loniten
Notice of alternative medication authorization, May 16, 2022 – Fludrocortisone acetate replaces Florinef
Notice of alternative medication authorization, May 16, 2022 – Fludrocortisone acetate (99113993) replaces Florinef
Notice of alternative medication authorization, May 16, 2022 – Fludrocortisone acetate (99113994) replaces Florinef
Notice of alternative medication authorization, May 4, 2022 – Octreotide acetate (99113995) replaces Sandostatin
Notice of alternative medication authorization, May 1, 2022 – Nutritional formula - casein Hydrolysate(infants and children) replaces:
- Alimentum
- NutramigenA+
- Presgestimil A+
- Nutramigen A+ LGG
Notice of alternative medication authorization, March 30, 2022 – Sodium phosphate monobasic / Sodium phosphate dibasic replaces Lax-A NEMA
Notice of alternative medication authorization, January 21, 2022 – carbamazepine (99113958) replaces:
- Taro-Carbamazepine
- Tegretol
Notice of alternative medication authorization, January 21, 2022 – carbamazepine (99113955) replaces:
- Taro-Carbamazepine
- Tegretol
Notice of alternative medication authorization, January 21, 2022 – carbamazepine (99113954) replaces:
- Taro-Carbamazepine
- Tegretol
Notice of alternative medication autorization, January 21, 2022 – hydrocortisone replaces Sandoz Hydrocortisone

Notice of alternative medication authorization, December 16, 2021 – Medroxyprogesterone acetate (99113945) replaces Apo-Medroxy
Notice of alternative medication authorization, December 7, 2021 – Progesterone replaces ACT Progesteron Injection
Notice of alternative medication authorization, December 2, 2021 – Medroxyprogesterone acetate (99113940) replaces:
- Apo-Medroxy
- Novo-Medrone
Notice of alternative medication authorization, December 2, 2021 – Medroxyprogesterone acetate (99113939) replaces:
- Apo-Medroxy
- Novo-Medrone
Notice of alternative medication authorization, December 2, 2021 – Medroxyprogesterone acetate (99113938) replaces:
- Apo-Medroxy
- Novo-Medrone
- Provera
Notice of alternative medication authorization, December 2, 2021 – Sulfasalazine replaces pms-Sulfasalazine
Notice of alternative medication authorization, November 30, 2021 – Famatidine replaces Novo-Famotidine
Notice of alternative medication authorization, November 25, 2021 – Medroxyprogesterone acetate (99113947) replaces
- Apo-Medroxy
- Novo-Medroxy
Notice of alternative medication authorization, November 25, 2021 – Medroxyprogesterone acetate (99113937) replaces :
- Apo-Medroxy
- Novo-Medrone
Notice of alternative medication authorization, November 25, 2021 – Medroxyprogestérone acetate (99113933) replaces:
- Apo-Medroxy
- Novo-Medrone
Notice of alternative medication authorization, August 20, 2021 – Estrone replaces Estragyn vaginal cream
Notice of alternative medication authorization, July 8, 2021 – Metroxyprogesterone acetate replaces Depo-Provera
Notice of alternative medication authorization, May 28, 2021 – Atropine sulfate 5 ml replaces:
- Atropine
- Isopto Atropine
Notice of alternative medication authorization, May 28, 2021 – Atropine sulfate 0.5 ml replaces:
- Atropine
- Isopto Atropine
Notice of alternative medication authorization, May 20, 2021 – Phenelzine sulfate replaces Phenelzine sulfate
Notice of alternative medication authorization, May 19, 2021 – Trifluoperazine hydrochlorhide replaces Trifluoperazine
Notice of alternative medication authorization, May 18, 2021 – Sodium chloride replaces Nebusal 7%
Notice of alternative medication authorization, May 11, 2021 – Bacitracine replaces Bacitracin
Notice of alternative medication authorization, April 13, 2021 – Pindolol replaces:
- Apo-Pindol
- Novo-Pindol
- Visken
Notice of alternative medication authorization, April 6, 2021 – Pindolol replaces:
- Apo-Pindol
- Novo-Pindol
- Visken
Notice of alternative medication authorization, April 6, 2021 – Pindolol replaces:
- Apo-Pindol
- Novo-Pindol
- Visken
Notice of alternative medication authorization, March 12, 2021 – Sodium phosphate monobasic and dibasic replaces:
- Fleet
- Lax-A NEMA
Notice of alternative medication authorization, February 18, 2021 – Ibuprofen replaces Europrofen
Notice of alternative medication authorization, February 18, 2021 – Metoprolol tartrate replaces:
- Lopresor SR
- Metoprolol SR
- Sandoz Metoprolol SR
Notice of alternative medication authorization, February 9, 2021 – Trifluoperazine hydrochloride replaces Trifluoperazine
Notice of alternative medication authorization, February 2, 2021 – Trifluoperazine hydrochloride replaces Trifluoperazine
Notice of alternative medication authorization, January 15, 2021 – Hydromorphone hydrochloride replaces pms-Hydromorphone
Notice of alternative medication authorization, January 8, 2021 – Nicoumalone replaces Sintrom

List of medications

Notices of replacement

Register

How did we do?

List of medications

Note on the Regulation respecting the List of medications

Notices of replacement

Recent notices

2024 notices

2023 notices

2022 notices

2021 notices

Register

2024

2023

2022

2021

How did we do?